Rapamycin Reverses The Hepatic Response To Diet-Induced Metabolic Stress That Is Amplified By Aging
As we age, our bodies often become more susceptible to various health challenges. A recent study sheds light on how aging specifically impacts the liver’s response to an unhealthy diet, such as one high in fat. It turns out that getting older significantly worsens the liver’s reaction to this kind of dietary stress, making it more prone to severe conditions like fatty liver disease, also known as metabolic-associated steatohepatitis (MASH). This means that older individuals on a high-fat diet experience more pronounced inflammation and disruptions in how their genes function (transcriptional dysregulation) compared to younger individuals on the same diet. The liver, which plays a crucial role in metabolism, struggles more to maintain a healthy balance (metabolic homeostasis) as we age when faced with dietary challenges. The good news is that the research identified a promising intervention: rapamycin. This compound was found to effectively counteract many of these age-exacerbated negative changes in the liver. Treatment with rapamycin reversed the increased inflammation, improved the disrupted gene activity, reduced fat accumulation in the liver (hepatosteatosis), and even lowered overall body weight in aged mice on a high-fat diet. These findings suggest that rapamycin could be a valuable tool in restoring liver health and preventing the progression of diet-related diseases in older populations, offering a new avenue for addressing age-related metabolic vulnerabilities.
Source: link to paper